Skip to main navigation
Skip to search
Skip to main content
University of Portsmouth Home
Help & FAQ
Home
Profiles
Organisations
Research outputs
Student theses
Datasets
Projects
Activities
Prizes
Press/Media
Equipment
Search by expertise, name or affiliation
P2X7 purinoceptor as a therapeutic target in muscular dystrophies
Dariusz C. Górecki
Institute of Life Sciences and Healthcare
Research output
:
Contribution to journal
›
Article
›
peer-review
333
Downloads (Pure)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'P2X7 purinoceptor as a therapeutic target in muscular dystrophies'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
INIS
muscles
100%
atp
100%
mutations
60%
death
40%
diseases
40%
inflammation
40%
mice
40%
levels
20%
damage
20%
patients
20%
therapy
20%
losses
20%
environment
20%
pathology
20%
repair
20%
symptoms
20%
genes
20%
genetics
20%
inhibition
20%
ablation
20%
phenotype
20%
receptors
20%
regeneration
20%
myoblasts
20%
Medicine and Dentistry
Muscular Dystrophy
100%
Purinergic P2X7 Receptor
100%
Adenosine Triphosphate
100%
Diseases
40%
Dystrophin
40%
Adenosine Triphosphatase
40%
Sarcoglycan
40%
Upregulation
20%
Prematurity
20%
Receptor
20%
Serositis
20%
Immune Response
20%
Muscle Injury
20%
Duchenne Muscular Dystrophy
20%
Sarcoglycanopathy
20%
Dystrophinopathy
20%
Myoblast
20%
Immunocompetent Cell
20%
Pharmacology, Toxicology and Pharmaceutical Science
Adenosine Triphosphate
100%
Purinergic P2X7 Receptor
100%
Muscular Dystrophy
100%
Disease
40%
Adenosine Triphosphatase
40%
Dystrophin
40%
Sarcoglycan
40%
Mouse Model
20%
Receptor
20%
Inflammation
20%
Prematurity
20%
Muscle Injury
20%
Duchenne Muscular Dystrophy
20%
Dystrophinopathy
20%
Sarcoglycanopathy
20%
Biochemistry, Genetics and Molecular Biology
Adenosine Triphosphate
100%
Purinergic Receptor
100%
Dystrophin
40%
Sarcoglycan
40%
Mouse Model
20%
Genetic Ablation
20%
Upregulation
20%
Immune Response
20%
Immunocompetent Cell
20%
Ecto-ATPases
20%